Aerovate Therapeutics, Inc. (AVTE) has 39 open-market insider trades by 10 insiders since 2021. The most active filer is Benjamin T. Dake.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Rajeev M. Shah | Dir10% Owner | — | 2 | $42.1M | 2024-06-17 |
| David S. Grayzel | Dir | — | 2 | $8.2M | 2024-04-09 |
| Cormorant Global Healthcare Master Fund, LP | — | — | 1 | $7.0M | 2021-07-02 |
| Maha Katabi | Dir10% Owner | — | 1 | $5.0M | 2021-07-02 |
| Benjamin T. Dake | — | — | 18 | $4.6M | 2024-08-01 |
| Timothy P. Noyes | CEO | — | 5 | $1.6M | 2024-05-16 |
| George A. Eldridge | — | — | 2 | $879K | 2024-06-14 |
| Ralph Niven | CSO | — | 3 | $166K | 2024-02-05 |
| Marinus Verwijs | CTO | — | 4 | $89K | 2024-06-14 |
| Hunter Gillies | — | — | 1 | $78K | 2024-06-13 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Rajeev M. Shah | Director & 10% Owner | Buy | $3.1M | 2024-06-17 |
| George A. Eldridge | — | Sell | $375K | 2024-06-14 |
| Marinus Verwijs | CTO | Sell | $265K | 2024-06-14 |
| Hunter Gillies | — | Sell | $147K | 2024-06-13 |
| Hunter Gillies | — | Sell | $167K | 2024-05-17 |
| Timothy P. Noyes | CEO | Sell | $403K | 2024-05-16 |
Companies that share insiders with AVTE, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Marinus Verwijs | CHIEF TECHNICAL OFFICER | Sell | $42K | 2024-05-02 |
| Timothy P. Noyes | CEO | Sell | $415K | 2024-05-01 |
| Hunter Gillies | — | Sell | $172K | 2024-04-17 |
| Benjamin T. Dake | — | Sell | $297K | 2024-04-17 |
| Timothy P. Noyes | CEO | Sell | $494K | 2024-04-16 |
| George A. Eldridge | — | Sell | $382K | 2024-04-10 |
| David S. Grayzel | Director | Sell | $669K | 2024-04-09 |
| George A. Eldridge | — | Sell | $780K | 2024-04-01 |
| Marinus Verwijs | CTO | Sell | $264K | 2024-04-01 |